Total Payments
$90,379
2024 Payments
$1,039
Companies
28
Transactions
284
Medicare Patients
26,522
Medicare Billing
$5.0M
Payment Breakdown by Category
Consulting$81,600 (90.3%)
Food & Beverage$8,377 (9.3%)
Travel$314.33 (0.3%)
Education$87.14 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $81,600 | 60 | 90.3% |
| Food and Beverage | $8,377 | 219 | 9.3% |
| Travel and Lodging | $314.33 | 2 | 0.3% |
| Education | $87.14 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $83,406 | 81 | $0 (2022) |
| Acutus Medical, Inc. | $1,160 | 11 | $0 (2022) |
| Abbott Laboratories | $678.24 | 6 | $0 (2024) |
| Medtronic Vascular, Inc. | $554.67 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $512.81 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $505.75 | 31 | $0 (2024) |
| BAXTER HEALTHCARE | $450.60 | 4 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $433.39 | 25 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $414.59 | 8 | $0 (2021) |
| ABIOMED | $357.40 | 21 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,039 | 38 | Abbott Laboratories ($243.11) |
| 2023 | $946.63 | 36 | Novartis Pharmaceuticals Corporation ($198.91) |
| 2022 | $2,556 | 37 | BIOTRONIK INC. ($1,600) |
| 2021 | $5,344 | 32 | BIOTRONIK INC. ($4,892) |
| 2020 | $3,612 | 18 | BIOTRONIK INC. ($2,800) |
| 2019 | $24,659 | 36 | BIOTRONIK INC. ($24,000) |
| 2018 | $27,589 | 48 | BIOTRONIK INC. ($26,912) |
| 2017 | $24,633 | 39 | BIOTRONIK INC. ($23,202) |
All Payment Transactions
284 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.38 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.85 | General |
| Category: Cardiovascular | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $32.28 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $18.54 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $83.69 | General |
| Category: Cardiology | ||||||
| 08/02/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Cardiology | ||||||
| 07/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Cardiology | ||||||
| 07/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/26/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $53.71 | General |
| Category: Cardiology | ||||||
| 06/25/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.19 | General |
| 06/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 5,496 | 10,842 | $4.3M | $807,736 |
| 2022 | 51 | 6,262 | 15,749 | $5.2M | $1.3M |
| 2021 | 57 | 7,596 | 23,502 | $6.1M | $1.5M |
| 2020 | 50 | 7,168 | 22,815 | $6.2M | $1.5M |
Total Patients
26,522
Total Services
72,908
Medicare Billing
$5.0M
Procedure Codes
203
All Medicare Procedures & Services
203 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 571 | 574 | $2.6M | $378,487 | 14.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 407 | 407 | $439,560 | $56,345 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 416 | 624 | $137,280 | $55,857 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 516 | 781 | $148,390 | $51,719 | 34.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 181 | 819 | $85,995 | $38,758 | 45.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 142 | 864 | $112,320 | $32,718 | 29.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 151 | 779 | $93,480 | $29,009 | 31.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 120 | 663 | $106,080 | $25,774 | 24.3% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 17 | 17 | $90,100 | $18,588 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 108 | 108 | $36,720 | $12,117 | 33.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 572 | 575 | $40,250 | $11,447 | 28.4% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 12 | 24 | $19,200 | $9,789 | 51.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 185 | 505 | $36,630 | $9,704 | 26.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 657 | 887 | $70,960 | $8,925 | 12.6% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 47 | 59 | $19,765 | $6,178 | 31.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 84 | 89 | $10,680 | $5,174 | 48.4% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 30 | 30 | $19,414 | $5,056 | 26.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 95 | 95 | $40,850 | $5,008 | 12.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 20 | 84 | $7,560 | $3,878 | 51.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 474 | 602 | $18,060 | $3,859 | 21.4% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 47 | 67 | $12,060 | $3,715 | 30.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 125 | 153 | $13,005 | $3,493 | 26.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 55 | $16,225 | $3,436 | 21.2% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 21 | 21 | $21,000 | $2,780 | 13.2% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 74 | 83 | $16,600 | $2,303 | 13.9% |
About Dr. William Resh, MD
Dr. William Resh, MD is a Cardiovascular Disease healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083637235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Resh, MD has received a total of $90,379 in payments from pharmaceutical and medical device companies, with $1,039 received in 2024. These payments were reported across 284 transactions from 28 companies. The most common payment nature is "Consulting Fee" ($81,600).
As a Medicare-enrolled provider, Resh has provided services to 26,522 Medicare beneficiaries, totaling 72,908 services with total Medicare billing of $5.0M. Data is available for 4 years (2020–2023), covering 203 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Las Vegas, NV
- Active Since 07/26/2006
- Last Updated 08/20/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1083637235
Products in Payments
- Edora (Device) $6,000
- Itrevia (Device) $1,600
- Rivacor 7 DR-T (Device) $1,600
- XARELTO (Drug) $505.75
- Resolute (Device) $434.67
- LifeVest (Device) $414.59
- Impella (Device) $357.40
- FLOSEAL (Biological) $337.34
- ELIQUIS (Drug) $331.15
- LEQVIO (Drug) $268.97
- BioMonitor 2 (Device) $261.65
- ENTRESTO (Drug) $243.84
- WATCHMAN FLX (Device) $198.99
- Repatha (Biological) $178.02
- Assure WCD (Device) $173.38
- CardioMEMS HF System (Device) $161.03
- CARDIOMEMS (Device) $159.96
- CAMZYOS (Drug) $149.52
- OPTIMIZER SMART SYSTEM (Device) $138.04
- AVEIR (Device) $137.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Las Vegas
Dr. Cres Miranda, Md, MD
Cardiovascular Disease — Payments: $1.1M
Cardiovascular Disease $1.1M
Dr. Arjun Gururaj, Md, MD
Cardiovascular Disease — Payments: $344,836
Cardiovascular Disease $344,836
Dr. Claudio Bonometti, M.d, M.D
Cardiovascular Disease — Payments: $199,383
Cardiovascular Disease $199,383
Mr. Nayab Zafar, M.d, M.D
Cardiovascular Disease — Payments: $140,841
Cardiovascular Disease $140,841
Branavan Umakanthan, D.o, D.O
Cardiovascular Disease — Payments: $116,213
Cardiovascular Disease $116,213
Niuton Koide, Md, MD
Cardiovascular Disease — Payments: $112,192
Cardiovascular Disease $112,192